BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 20019167)

  • 1. New insights into epithelial-mesenchymal transition in kidney fibrosis.
    Liu Y
    J Am Soc Nephrol; 2010 Feb; 21(2):212-22. PubMed ID: 20019167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.
    Liu Y
    J Am Soc Nephrol; 2004 Jan; 15(1):1-12. PubMed ID: 14694152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.
    Li Y; Yang J; Dai C; Wu C; Liu Y
    J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis.
    Lee K; Nelson CM
    Int Rev Cell Mol Biol; 2012; 294():171-221. PubMed ID: 22364874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts.
    Barnes JL; Glass Ii WF
    Contrib Nephrol; 2011; 169():73-93. PubMed ID: 21252512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against.
    Fragiadaki M; Mason RM
    Int J Exp Pathol; 2011 Jun; 92(3):143-50. PubMed ID: 21554437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal plasticity in kidney fibrosis.
    Hadpech S; Thongboonkerd V
    Genesis; 2024 Feb; 62(1):e23529. PubMed ID: 37345818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts.
    Özdemir BH; Özdemir AA; Colak T; Sezer S; Haberal M
    Transplant Proc; 2011 Mar; 43(2):527-9. PubMed ID: 21440751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling.
    Hu L; Ding M; He W
    Front Pharmacol; 2021; 12():830340. PubMed ID: 35082683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
    Burns WC; Kantharidis P; Thomas MC
    Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase.
    Li Y; Dai C; Wu C; Liu Y
    J Am Soc Nephrol; 2007 Sep; 18(9):2534-43. PubMed ID: 17656471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.
    Burns WC; Thomas MC
    Expert Rev Mol Med; 2010 May; 12():e17. PubMed ID: 20504380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMT and proteinuria as progression factors.
    Strutz FM
    Kidney Int; 2009 Mar; 75(5):475-81. PubMed ID: 18716603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epithelial-to-mesenchymal transition in renal fibrosis.
    Zeisberg M; Kalluri R
    J Mol Med (Berl); 2004 Mar; 82(3):175-81. PubMed ID: 14752606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
    Choi D; Kim CL; Kim JE; Mo JS; Jeong HS
    Biochem Biophys Res Commun; 2020 Jul; 528(1):154-159. PubMed ID: 32451085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
    Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein promotes epithelial-mesenchymal transition.
    Ardura JA; Rayego-Mateos S; Rámila D; Ruiz-Ortega M; Esbrit P
    J Am Soc Nephrol; 2010 Feb; 21(2):237-48. PubMed ID: 19959711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epithelial-mesenchymal transition and fibrosis of the renal transplant].
    Mezni I; Galichon P; Bacha MM; Sfar I; Hertig A; Goucha R; Xu-Dubois YC; Abderrahim E; Gorgi Y; Rondeau E; Abdallah TB
    Med Sci (Paris); 2015 Jan; 31(1):68-74. PubMed ID: 25658733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
    Kang YS; Li Y; Dai C; Kiss LP; Wu C; Liu Y
    Kidney Int; 2010 Aug; 78(4):363-73. PubMed ID: 20505657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.